Entries by Dr Andrew Tan

Lutetium-177 Octreotate Therapy: Your Questions Answered

What Is Lutetium-177 Octreotate Therapy? One of the therapies used to treat neuroendocrine tumours is Lutetium-177 Octreotate Therapy. It is a targeted radioligand therapy that specially targets tumours that express somatostatin receptors (i.e. neuroendocrine tumours).  Its method of action consists of using peptide molecules such as artificial octreotate – transport – linked to a carrier […]

Yttrium-90 Selective Internal Radiation Therapy (SIRT): Your Questions Answered

What Is Yttrium-90 Selective Internal Radiation Therapy (SIRT)? Yttrium-90 Selective Internal Radiation Therapy (SIRT) is known as radioembolisation, and its purpose is to eliminate tumours located in the liver. It involves the injection of small radioactive particles directly into the liver artery. These beads emit short-range radiation, which targets the tumour but minimises damage to […]

, ,

What Is Theranostics?

What Is Theranostics? Theranostics is a viable method of treating cancer, especially when the cancer cells have spread or are at a more advanced stage and are unable to respond to other treatments. While there is still a lot of potential to replicate the procedure for other types of cancers, to date, theranostics has shown […]

Coping With Neuroendocrine Tumours (NETs): Your Symptoms, Well-Being, and Finding Support

What Are Neuroendocrine Tumours (NETs)? Neuroendocrine Tumours (NETs) are rare tumours that affect specialised cells known as neuroendocrine cells. The peculiarity of this type of cell resides in that they have traits similar to nerve cells and hormone-producing cells. Neuroendocrine cells are found in all organs of an individual and help control many of their […]

What to Expect: Lutetium-177 Octreotate Therapy

What Is Lutetium-177 Octreotate Therapy?  One of the therapies used to treat neuroendocrine tumours is Lutetium-177 Octreotate Therapy. It is a targeted radioligand therapy that specially targets tumours that express somatostatin receptors (i.e. neuroendocrine tumours).  Its method of action consists of using peptide molecules such as artificial octreotate – transport – linked to a carrier […]

What to Expect: Yttrium-90 Selective Internal Radiation Therapy (SIRT)

What Is Yttrium-90 Selective Internal Radiation Therapy (SIRT) Yttrium-90 Selective Internal Radiation Therapy (SIRT) is known as radioembolisation, and its purpose is to eliminate tumours located in the liver. It works as small radioactive beads that migrate to the tumour through one’s arteries. These beads emit short-range radiation, which targets the tumour but minimises damage […]

Neuroendocrine Tumours (NET): Causes, Symptoms, Diagnosis, Treatment

What Are Neuroendocrine Tumours (NETs)? Neuroendocrine Tumours (NETs) are rare tumours that affect specialised cells known as neuroendocrine cells. The peculiarity of this type of cell resides in that they have traits similar to nerve cells and hormone-producing cells. Neuroendocrine cells are found in all organs of the individual and help control many of their […]

What to Expect: Radium-223 Therapy (Xofigo) 

What Is Radium-223 Therapy (Xofigo)?  Radium-223 Therapy (Xofigo) is a form of targeted radioactive therapy. It is a type of radioactive treatment that targets sclerotic bony metastases. What Is Prostate Cancer? Prostate cancer is one of the most common cancers among men. Approximately 1 in 9 men will be diagnosed with prostate cancer in their […]